Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 67Colorectal Neoplasms 36Central Nervous System Neoplasms 36Colonic Neoplasms 34Rectal Neoplasms 32Glioblastoma 23Gliosarcoma 20Carcinoma, Non-Small-Cell Lung 20Lung Neoplasms 18Stomach Neoplasms 16Pancreatic Neoplasms 15Sarcoma 14Ovarian Neoplasms 13Head and Neck Neoplasms 13Prostatic Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Neoplasm Metastasis 11Melanoma 11Astrocytoma 11Esophageal Neoplasms 10Carcinoma, Ovarian Epithelial 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Kidney Neoplasms 9Fallopian Tube Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 9Breast Carcinoma In Situ 9Breast Neoplasms, Male 8Adenocarcinoma Of Esophagus 8Liver Neoplasms 7

Interventions

Pemetrexed 14Carboplatin 13osimertinib 10aflutinib 9Drug Therapy 9Gefitinib 7Radiotherapy 6Docetaxel 6Cisplatin 6anlotinib 5Radiosurgery 5Paclitaxel 5pembrolizumab 4Vinorelbine 4Gemcitabine 4tislelizumab 3icotinib 3apatinib 3HM781-36B 3Erlotinib Hydrochloride 3toripalimab 2spartalizumab 2rezivertinib 2camrelizumab 2Tyrosine Kinase Inhibitors 2Thalidomide 2Surgical Procedures, Operative 2S 1 (combination) 2Platinum 2Immune Checkpoint Inhibitors 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × NSCLC × Chemotherapy, Adjuvant × Clear all
NCT07089199 2025-07-28

TitAN

Qilu Hospital of Shandong University

Phase 2 Not yet recruiting
34 enrolled
Thoracic

NSCLC

NCT05286957 2023-03-17

Seagull

The First Affiliated Hospital of Zhengzhou University

Phase 2 Recruiting
60 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡